China State Council Unveils Pro-Pharma Policies, But Will They Work?
This article was originally published in PharmAsia News
In a new policy push, China's Cabinet has listed major goals to propel the country to become the next destination for pharma innovation, with antibodies, therapeutic vaccines and peptides among the priority fields. But doubts remain given scant details on how regulators will work together to achieve the lofty goals.
Register for our free email digests: